Stay up to date with the latest developments, partnerships, and milestones at SWL Pharma.
Sifat Wahdati Limited attended CPHI Milan 2026, engaging in high-level discussions with leading pharmaceutical companies from around the world.
Over three productive days in Milan, our team held meetings with global manufacturers including Troikaa Pharmaceuticals, Medical Union Pharmaceuticals, Brawn Group, Humanis, Aurobindo Pharma, Eva Pharma, USV, Hetero, Meiji Seika Pharma, and Bluepharma — reflecting our continued commitment to bringing high-quality, affordable medicines to Afghanistan and expanding access through strong international partnerships.
We look forward to developing new partnerships in the near future. Thank you to everyone who met with our team and shared our vision of building a healthier nation.










As Day One concluded at CPHI Milan, SWL reflected on a productive day of discussions with leading pharmaceutical companies. These conversations reflect our continued commitment to bringing high-quality, affordable medicines to Afghanistan and expanding access through strong international partnerships.

As CPHI Milan came to a close, days two and three built on a great start with productive meetings across the globe. SWL remains committed to bringing quality, affordable medicines to Afghanistan and looks forward to developing new partnerships.

As DUPHAT 2026 Dubai came to a close, the SWL team reflected on a highly successful exhibition with valuable meetings and discussions with pharmaceutical manufacturers and suppliers from around the world. We look forward to following up on these opportunities and building new partnerships that support our commitment to bringing quality medicines to Afghanistan.




SWL Pharma welcomes Matrix Pharma to its growing portfolio of global pharmaceutical partners. This alliance brings a wide range of therapeutic categories to Afghanistan's healthcare network, filling critical gaps in medicine availability across the country.
Read Full Story →SWL Pharma has successfully renewed all regulatory certifications from both the Ministry of Commerce & Industry and the Ministry of Public Health of the Islamic Emirate of Afghanistan — reaffirming our commitment to full legal compliance and operational transparency.
Read Full Story →We are proud to announce that our team has grown to over 400 dedicated professionals — from logistics and warehousing to regulatory affairs and sales. This growth reflects our expanding operations and deepening commitment to Afghanistan's healthcare sector.
Read Full Story →SWL Pharma has deepened its distribution agreement with Hilton Pharma, expanding the range of high-quality generic medicines available to Afghan healthcare providers at affordable prices. This partnership directly benefits patients across all 34 provinces.
Read Full Story →Our leadership team represented SWL Pharma at the annual Kabul Healthcare Forum, engaging with ministry officials, hospital administrators, and international NGOs on improving pharmaceutical access and supply chain resilience across Afghanistan.
Read Full Story →2023 marks 17 years since Sifat Wahdati Limited was founded in Kabul. From a small team to a nationally recognised pharmaceutical distributor, we reflect on our journey and reaffirm our mission to improve healthcare access for all Afghans.
Read Full Story →